This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (2945) mHealth in a Clinical Setting (616) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1402)

Published on in Vol 24, No 9 (2022): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37445, first published .
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Authors of this article:

Esther Chamorro-de-Vega1, 2 Author Orcid Image ;   Rosa Romero-Jiménez2 Author Orcid Image ;   Vicente Escudero-Vilaplana2 Author Orcid Image ;   Arantza Ais-Larisgoitia2 Author Orcid Image ;   María Elena Lobato Matilla2 Author Orcid Image ;   Carlos M González3 Author Orcid Image ;   Luis Menchén4, 5 Author Orcid Image ;   Ofelia Baniandrés6 Author Orcid Image ;   Lucía Ibares-Frias7 Author Orcid Image ;   Carmen Lobo-Rodríguez8 Author Orcid Image ;   Ana Herranz-Alonso2 Author Orcid Image ;   María Sanjurjo2 Author Orcid Image
Article Authors Cited by (4) Tweetations (9) Metrics

Journals

  1. Cobelli N, Cassia F, Zardini A, Kuppelwieser V. Pharmacies providing health services: Attitudes toward eHealth in Italy. Journal of Retailing and Consumer Services 2024;76:103568 View
  2. Ni Z, Zhu L, Li S, Zhang Y, Zhao R. Characteristics and associated factors of health information-seeking behaviour among patients with inflammatory bowel disease in the digital era: a scoping review. BMC Public Health 2024;24(1) View
  3. López Sánchez P, Palanques Pastor T, Ibarra Barrueta O, Ramírez Herráiz E, Casellas Gibert M, Monte Boquet E. Análisis de la situación de la atención farmacéutica a pacientes con enfermedades inflamatorias inmunomediadas antes y después de la pandemia COVID-19. Farmacia Hospitalaria 2024 View
  4. López Sánchez P, Palanques Pastor T, Ibarra Barrueta O, Ramírez Herráiz E, Casellas Gibert M, Monte Boquet E. Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic. Farmacia Hospitalaria 2024 View